7 Mid Cap Stocks Hit 52-Week Highs On Wednesday
A handful of stocks reach new highs against a falling market, with a notable concentration in one part of the economy.
The S&P 500 has returned -2.4% over the last month, a period where some names are finding new strength. As of Wednesday, September 16, there are 7 Mid Cap US and Canada-listed stocks in the Trefis coverage universe trading at their 52-week highs.
Four of those names are in the Health Care sector. This raises the question of whether today’s strength is narrowly concentrated or if the individual stories are more varied than the sector count suggests.
The Full List, Largest First
Here are all 7 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| ILMN | $34.57 Bil | 3.0% | 11.7% | 18.5% | 126.8% |
| DGX | $27.43 Bil | 0.0% | 4.9% | 4.9% | 39.2% |
| DINO | $20.45 Bil | 1.5% | 5.4% | 20.0% | 127.9% |
| RVTY | $16.26 Bil | 4.0% | 17.7% | 25.4% | 74.0% |
| DT | $16.13 Bil | 0.0% | 9.1% | 15.9% | 13.5% |
| CRBG | $15.83 Bil | 0.2% | 3.8% | 5.8% | 11.7% |
| AVTR | $10.56 Bil | 1.1% | 4.9% | 15.6% | 26.0% |
This screen covers US and Canada-listed stocks in the Trefis coverage universe. Mid Cap here means a market value between $10 billion and $40 billion, the upper figure excluded.
The List Includes Both High-Multiple Growth and Low-Multiple Value.
The names reaching new highs show very different financial profiles. Dynatrace (DT) trades at 106.5 times trailing earnings, while its revenue grew 17.9% over the last twelve months and its operating margin was 13.0%.
In contrast, HF Sinclair (DINO) trades at 10.7 times trailing earnings. That multiple is on trailing earnings that include at least one loss quarter, so the multiple is not comparable to a clean-year multiple. The company’s revenue grew 16.3% over the last twelve months, and its operating margin was 8.4%.
A High Price Is a Question, Not an Answer.
A list of stocks at their highest price of the past year is a useful screen for strength. Strong price action can persist.
But a price is not a verdict on a business. The disciplined next step is to look past the chart and ask if the company’s fundamentals justify the new valuation. The work begins at the high, it does not end there.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
New Highs Fade. Discipline Compounds
Some of the names on this list will keep setting highs for years, and some are at the top of their run right now. Sorting one from the other, name by name, every day, is the work most investors never keep up with.
That sorting is what the Trefis High Quality (HQ) Portfolio does systematically: about 30 quality businesses screened for the fundamentals that sustain a run, held with rules instead of excitement. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Use the high list for ideas; use the portfolio for the compounding.